Clinical Research Showcase

Clinical Research Showcase

Professor Joe O'Sullivan

IMPROVING CLINICAL CANCER RESEARCH

Clinical research is a fundamental part of a modern comprehensive cancer service.

Participation in clinical trials improves the quality of care of all patients treated at the Cancer Centre and helps develop the next generation of cancer therapies. The Clinical Research Showcase is a forum to learn about the high quality clinical-translational cancer research currently being conducted in Belfast.

In the Centre for Cancer Research and Cell Biology (CCRCB) and Northern Ireland Cancer Centre (NICC) many multidisciplinary groups are involved in world-class cancer research with our clinicians and scientists regularly presenting cutting-edge research at national and international conferences. We want to provide a forum for staff to hear about this research in Belfast with expert lectures held every two months in the Grand Rounds slot at 9.00 am in Seminar Room 3, NI Cancer Centre. The Clinical Research Showcase (CRS) welcomes staff from the CCRCB and the Clinical Cancer Centre including scientists, NHS and academic clinicians, research nurses and radiographers, pharmacists, medical physicists as well as patient and public involvement (PPI).

Close collaboration locally with the Cancer Centre and nationally with CRUK Centres and the Experimental Cancer Medicine Centres Network are integral to our development. The central focus of our translational research programme is to accelerate predictive biomarker discovery and to target discovery and validation for novel and effective therapeutic intervention in cancer. Our clinical trials programme is particularly strong in Prostate Cancer, Gastrointestinal Cancers, Haematological Malignancies and Radiation Therapy.

We hope that the CRS will be a highly stimulating meeting for all staff across the Cancer Centre and CCRCB.

Chairs: Dr Gerry Hanna, Dr Vicky Coyle, Dr Suneil Jain

Enquiries to: Kiera McGill (k.mcgill@qub.ac.uk)

The Clinical Research Showcase has a number of key partners including:

PREVIOUS SECTION

Research

NEXT SECTION

Focus Groups